HealthQuill T-cells
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages of small cell lung cancer (ES-SCLC) with disease progression on or after chemotherapy.
Drugs Health Pharma

USFDA gives nod to Amgen’s therapy for treating small cell lung cancer 

HQ Team May 17, 2024: The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages.

Read More
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s top research institutes, Karolinska Institutet, wrote in a study.
Drugs Medical Pharma

Blood cancer therapy may help to treat ovarian cancer: Swedish scientists

A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.

Read More
AstraZeneca
Drugs Health Medical Pharma

AstraZeneca to buy Neogene for $320 million

AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million

Read More
X